インフレ削減法が希少疾患の医薬品開発に与える影響

多くの患者にとってこのような利点があるにもかかわらず、新法はすでに希少疾病患者のための新薬の発見と開発に影響を及ぼしています。Not only are drugs that could treat more than one disease being disincentivized, small molecule medicines, which play an important role in treating neurological disorders, cancers, and other diseases, may also be disadvantaged by the law.